Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 4.5B | 6.5B | 4.9B |
Cost of revenue | 2.5B | 2.7B | 3.8B | 3.2B |
Gross profit | 1.9B | 1.8B | 2.8B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 412.0M | 599.8M | 697.0M | 565.4M |
Operating income | 923.0M | 625.0M | 1.5B | 594.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 17.9M | 14.3M | 10.5M | 8.3M |
Other income expense | — | — | — | — |
Pretax income | 1.0B | 680.8M | 1.6B | 657.4M |
Tax provision | 261.6M | 130.3M | 391.4M | 168.5M |
Net income | 755.0M | 550.4M | 1.2B | 489.0M |
Basic EPS | — | 12.3 | 25.8 | 10.7 |
Diluted EPS | — | 12.3 | 25.8 | 10.7 |
Basic average shares | — | 44.9M | 45.5M | 45.6M |
Diluted average shares | — | 44.9M | 45.5M | 45.6M |
EBITDA | 1.2B | 825.7M | 1.7B | 788.6M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |